Viewing Study NCT02959918


Ignite Creation Date: 2025-12-25 @ 4:36 AM
Ignite Modification Date: 2026-03-11 @ 6:23 AM
Study NCT ID: NCT02959918
Status: COMPLETED
Last Update Posted: 2022-02-14
First Post: 2016-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
Sponsor: Selecta Biosciences, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-10
Start Date Type: ACTUAL
Primary Completion Date: 2018-12
Primary Completion Date Type: ACTUAL
Completion Date: 2019-01
Completion Date Type: ACTUAL
First Submit Date: 2016-11-06
First Submit QC Date: None
Study First Post Date: 2016-11-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-04-02
Results First Submit QC Date: None
Results First Post Date: 2022-02-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-01-31
Last Update Post Date: 2022-02-14
Last Update Post Date Type: ACTUAL